Current Ratio
since 2005
Calculation
Pfizer Inc., current ratio, long-term trends, calculation
| Current ratio | = | Current assets1 | ÷ | Current liabilities1 | |
|---|---|---|---|---|---|
| Dec 31, 2023 | 0.91 | = | 43,333) | ÷ | 47,794) |
| Dec 31, 2022 | 1.22 | = | 51,259) | ÷ | 42,138) |
| Dec 31, 2021 | 1.40 | = | 59,693) | ÷ | 42,671) |
| Dec 31, 2020 | 1.35 | = | 35,067) | ÷ | 25,920) |
| Dec 31, 2019 | 0.88 | = | 32,803) | ÷ | 37,304) |
| Dec 31, 2018 | 1.57 | = | 49,926) | ÷ | 31,858) |
| Dec 31, 2017 | 1.35 | = | 41,141) | ÷ | 30,427) |
| Dec 31, 2016 | 1.25 | = | 38,949) | ÷ | 31,115) |
| Dec 31, 2015 | 1.49 | = | 43,804) | ÷ | 29,399) |
| Dec 31, 2014 | 2.67 | = | 57,702) | ÷ | 21,631) |
| Dec 31, 2013 | 2.41 | = | 56,244) | ÷ | 23,366) |
| Dec 31, 2012 | 2.15 | = | 61,415) | ÷ | 28,619) |
| Dec 31, 2011 | 2.06 | = | 57,728) | ÷ | 28,069) |
| Dec 31, 2010 | 2.11 | = | 60,468) | ÷ | 28,609) |
| Dec 31, 2009 | 1.66 | = | 61,670) | ÷ | 37,225) |
| Dec 31, 2008 | 1.59 | = | 43,076) | ÷ | 27,009) |
| Dec 31, 2007 | 2.15 | = | 46,849) | ÷ | 21,835) |
| Dec 31, 2006 | 2.20 | = | 46,949) | ÷ | 21,389) |
| Dec 31, 2005 | 1.47 | = | 41,896) | ÷ | 28,448) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in millions
Comparison to Competitors
Pfizer Inc., current ratio, long-term trends, comparison to competitors
| Pfizer Inc. | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2023 | 0.91 | 0.87 | 1.65 | 1.43 | 1.68 | 0.94 | 1.43 | 1.16 | 1.25 | 5.69 | 1.75 |
| Dec 31, 2022 | 1.22 | 0.96 | 1.41 | 1.25 | 1.89 | 1.05 | 1.29 | 0.99 | 1.47 | 5.06 | 1.48 |
| Dec 31, 2021 | 1.40 | 0.79 | 1.59 | 1.52 | 1.43 | 1.23 | 1.27 | 1.35 | 1.27 | 3.56 | 1.50 |
| Dec 31, 2020 | 1.35 | 0.84 | 1.81 | 1.58 | 1.86 | 1.40 | 1.40 | 1.21 | 1.02 | 3.63 | 2.13 |
| Dec 31, 2019 | 0.88 | 3.18 | 1.44 | 1.60 | 5.19 | 1.16 | 3.10 | 1.26 | 1.24 | 3.67 | 1.92 |
| Dec 31, 2018 | 1.57 | 0.98 | 2.79 | 1.61 | 1.47 | 1.73 | 3.38 | 1.47 | 1.17 | 4.47 | 1.73 |
| Dec 31, 2017 | 1.35 | 1.28 | 5.49 | 1.55 | 1.43 | 1.32 | 2.74 | 1.41 | 1.33 | 3.82 | 1.34 |
| Dec 31, 2016 | 1.25 | 1.65 | 4.11 | 1.55 | 0.97 | 1.37 | 2.22 | 2.47 | 1.78 | 2.56 | 1.44 |
| Dec 31, 2015 | 1.49 | 1.50 | 4.44 | 1.30 | 1.27 | 1.53 | 2.50 | 2.17 | 1.55 | 3.59 | 1.38 |
| Dec 31, 2014 | 2.67 | 1.41 | 4.95 | 1.73 | 1.75 | 1.09 | 3.07 | 2.36 | 1.77 | 3.31 | 1.22 |
| Dec 31, 2013 | 2.41 | 2.59 | 3.44 | 1.52 | 2.01 | 1.47 | 1.15 | 2.20 | 2.00 | 6.01 | 3.16 |
| Dec 31, 2012 | 2.15 | 2.27 | 3.81 | 1.15 | 1.80 | 1.55 | 1.44 | 1.90 | 1.90 | 7.37 | 2.31 |
| Dec 31, 2011 | 2.06 | — | 4.80 | 1.97 | 1.50 | 1.60 | 5.53 | 2.38 | 2.04 | 4.40 | 1.55 |
| Dec 31, 2010 | 2.11 | — | 3.52 | 1.97 | 1.73 | 2.09 | 2.32 | 2.05 | 1.86 | 3.28 | 2.42 |
| Dec 31, 2009 | 1.66 | — | 4.89 | 2.21 | 1.89 | 1.90 | 2.57 | 1.82 | 1.80 | 4.55 | 2.76 |
| Dec 31, 2008 | 1.59 | — | 3.12 | 2.20 | 1.53 | 0.95 | 3.52 | 1.65 | 1.35 | 6.23 | 2.82 |
| Dec 31, 2007 | 2.15 | — | 2.11 | 1.20 | 1.40 | 2.33 | 4.11 | 1.51 | 1.23 | 2.81 | 1.93 |
| Dec 31, 2006 | 2.20 | — | 1.67 | 1.59 | 1.38 | 1.91 | 3.18 | 1.20 | 1.20 | 10.44 | 1.70 |
| Dec 31, 2005 | 1.47 | — | 2.57 | 1.78 | 1.30 | 1.89 | 6.79 | 2.48 | 1.58 | 8.46 | 1.71 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Pfizer Inc., current ratio, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Pfizer Inc. | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Dec 31, 2023 | 0.91 | 1.23 |
| Dec 31, 2022 | 1.22 | 1.26 |
| Dec 31, 2021 | 1.40 | 1.33 |
| Dec 31, 2020 | 1.35 | 1.35 |
| Dec 31, 2019 | 0.88 | 1.65 |
| Dec 31, 2018 | 1.57 | 1.70 |
| Dec 31, 2017 | 1.35 | 1.73 |
| Dec 31, 2016 | 1.25 | 1.91 |
| Dec 31, 2015 | 1.49 | 1.90 |
| Dec 31, 2014 | 2.67 | 2.18 |
| Dec 31, 2013 | 2.41 | 2.16 |
| Dec 31, 2012 | 2.15 | 2.04 |
| Dec 31, 2011 | 2.06 | 2.29 |
| Dec 31, 2010 | 2.11 | 2.14 |
| Dec 31, 2009 | 1.66 | 1.94 |
| Dec 31, 2008 | 1.59 | 1.65 |
| Dec 31, 2007 | 2.15 | 1.74 |
| Dec 31, 2006 | 2.20 | 1.64 |
| Dec 31, 2005 | 1.47 | 1.81 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Pfizer Inc., current ratio, long-term trends, comparison to industry (health care)
| Pfizer Inc. | Health Care | |
|---|---|---|
| Dec 31, 2023 | 0.91 | 1.13 |
| Dec 31, 2022 | 1.22 | 1.15 |
| Dec 31, 2021 | 1.40 | 1.20 |
| Dec 31, 2020 | 1.35 | 1.20 |
| Dec 31, 2019 | 0.88 | 1.33 |
| Dec 31, 2018 | 1.57 | 1.38 |
| Dec 31, 2017 | 1.35 | 1.47 |
| Dec 31, 2016 | 1.25 | 1.68 |
| Dec 31, 2015 | 1.49 | 1.67 |
| Dec 31, 2014 | 2.67 | 1.87 |
| Dec 31, 2013 | 2.41 | 1.93 |
| Dec 31, 2012 | 2.15 | 1.81 |
| Dec 31, 2011 | 2.06 | 1.91 |
| Dec 31, 2010 | 2.11 | 1.80 |
| Dec 31, 2009 | 1.66 | 1.75 |
| Dec 31, 2008 | 1.59 | 1.42 |
| Dec 31, 2007 | 2.15 | 1.51 |
| Dec 31, 2006 | 2.20 | 1.39 |
| Dec 31, 2005 | 1.47 | 1.63 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).